image missing

Central European Annals of Clinical Research

(ISSN: 2668-7305) Open Access Journal
Follow us:
Rss Feed:

Central European Annals of Clinical Research (CEACR) is no longer published on JAMS (the publishing platform provided by MDPI) as of 10.07.2021. The articles published until that date are archived at ceacr.archive.jams.pub by courtesy of JAMS.

Cent_Eur_Ann_Clin_Res 2020, 2(1), 32; doi:10.35995/ceacr2010032

Endoped Abstract
Interpretation of Continuous Glucose Monitoring and Time in Range and Glycemic Control
Dorothy J Becker 1,2
1
School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA; dorothy.becker@chp.edu
2
Division of Endocrinology and Diabetes, Children’s Hospital of Pittsburgh, Pittsburgh, PA, USA
How to cite: Becker, D.J. Interpretation of Continuous Glucose Monitoring and Time in Range and Glycemic Control. Cent. Eur. Ann. Clin. Res. 2020, 2(1), 32; doi:10.35995/ceacr2010032.
Received: 20 October 2020 / Accepted: 29 October 2020 / Published: 30 October 2020
Keywords:
glucose monitoring; time in range; diabetes; child
More accurate continuous glucose monitors have provided a new tool for physicians and patients to assess glycemic control, detect the timing, frequency and potential causes of hypoglycemia, and most importantly, the effects of food and insulin blousing. There are pros and cons to the assessment of the concept of “time in range” for patient care and treatment changes. However, the proper use and careful evaluation of aily glucose excursions are extremely helpful for creating treatment strategies. This new tool can be used in addition to the measurement of HbA1c to assess risks for T1D complications, and research in this area is proceeding and will be discussed [1,2,3].

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Beck, R.W.; Bergenstal, R.M.; Riddlesworth, T.D.; Kollman, C.; Li, Z.; Brown, A.S.; Close, K.L. Validation of time in range as an outcome measure for diabetes clinical trials. Diabetes Care 2019, 42, 400–405. [Google Scholar] [CrossRef] [PubMed]
  2. Advani, A. Positioning time in range in diabetes management. Diabetologia 2020, 63, 242–252. [Google Scholar] [CrossRef] [PubMed]
  3. Danne, T. International consensus on Use of Continuous glucose monitoring. Diabetes Care 2017, 40, 1631–1640. [Google Scholar] [CrossRef] [PubMed]